Loading…
Advanced Glomerulosclerosis Is Reversible in Nephrotic Mice
Advanced glomerulosclerosis, a common hallmark of chronic renal diseases (CRD) is believed to be irreversible, and it is thought that glomerular hyperfiltration and hypertrophy may participate in its pathogenesis. We demonstrate here that glomerulosclerosis is “reversible” in an animal model. We use...
Saved in:
Published in: | Biochemical and biophysical research communications 2001-06, Vol.284 (3), p.707-713 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63 |
---|---|
cites | cdi_FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63 |
container_end_page | 713 |
container_issue | 3 |
container_start_page | 707 |
container_title | Biochemical and biophysical research communications |
container_volume | 284 |
creator | Mizuno-Horikawa, Yoko Mizuno, Shinya Tamura, Shinichi Kurosawa, Tsutomu |
description | Advanced glomerulosclerosis, a common hallmark of chronic renal diseases (CRD) is believed to be irreversible, and it is thought that glomerular hyperfiltration and hypertrophy may participate in its pathogenesis. We demonstrate here that glomerulosclerosis is “reversible” in an animal model. We used nephrotic ICGN (nep/nep) mice which showed a rapid progression of glomerulosclerosis, accompanied by histological findings for glomerular hyperfiltration. It is known that ureter ligation reduces glomerular filtration in ligated kidneys. When ureter ligation was applied to our model, glomerulosclerosis (characterized by myofibroblast hyperplasia and over-accumulated matrix protein) weakened in conjunction with suppressed glomerular hypertrophy. During this process, glomerular myofibroblasts showed apoptotic cell death after unilateral ureter ligation (UUO) treatment. Our results suggest that inhibition of glomerular filtration in sclerotic tufts may cause glomerular remodeling through the modulation of molecular and cellular sclerogenesis. |
doi_str_mv | 10.1006/bbrc.2001.4903 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70906677</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X01949034</els_id><sourcerecordid>70906677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63</originalsourceid><addsrcrecordid>eNp1kMFLwzAUh4Mobk6vHqUnb61JmqYrnoboHEwFUfAWkpdXjLTrTNqB_70pG3jy9HjwvR_v9xFyyWjGKJU3xnjIOKUsExXNj8iU0YqmnFFxTKY0Eimv2MeEnIXwFSkmZHVKJozllawknZLbhd3pDaBNlk3Xoh-aLkCDvgsuJKuQvOIOfXCmwcRtkmfcfvqud5A8OcBzclLrJuDFYc7I-8P9291jun5Zru4W6xRyQfvUGCihAMxNidIaXYjSaDnnaIFqAYYVtualKKSIFWwta5kXkjNe13lhqrjNyPU-d-u77wFDr1oXAJtGb7AbgipjZSnLMoLZHoT4f_BYq613rfY_ilE16lKjLjXqUqOueHB1SB5Mi_YPP_iJwHwPYOy3c-hVAIejL-cRemU791_2L2QXeVQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70906677</pqid></control><display><type>article</type><title>Advanced Glomerulosclerosis Is Reversible in Nephrotic Mice</title><source>ScienceDirect Journals</source><creator>Mizuno-Horikawa, Yoko ; Mizuno, Shinya ; Tamura, Shinichi ; Kurosawa, Tsutomu</creator><creatorcontrib>Mizuno-Horikawa, Yoko ; Mizuno, Shinya ; Tamura, Shinichi ; Kurosawa, Tsutomu</creatorcontrib><description>Advanced glomerulosclerosis, a common hallmark of chronic renal diseases (CRD) is believed to be irreversible, and it is thought that glomerular hyperfiltration and hypertrophy may participate in its pathogenesis. We demonstrate here that glomerulosclerosis is “reversible” in an animal model. We used nephrotic ICGN (nep/nep) mice which showed a rapid progression of glomerulosclerosis, accompanied by histological findings for glomerular hyperfiltration. It is known that ureter ligation reduces glomerular filtration in ligated kidneys. When ureter ligation was applied to our model, glomerulosclerosis (characterized by myofibroblast hyperplasia and over-accumulated matrix protein) weakened in conjunction with suppressed glomerular hypertrophy. During this process, glomerular myofibroblasts showed apoptotic cell death after unilateral ureter ligation (UUO) treatment. Our results suggest that inhibition of glomerular filtration in sclerotic tufts may cause glomerular remodeling through the modulation of molecular and cellular sclerogenesis.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1006/bbrc.2001.4903</identifier><identifier>PMID: 11396960</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis ; Fibroblasts ; Fibronectins - metabolism ; glomerular hypertrophy ; glomerular remodeling ; glomerulosclerosis ; Glomerulosclerosis, Focal Segmental - metabolism ; Glomerulosclerosis, Focal Segmental - pathology ; Glomerulosclerosis, Focal Segmental - therapy ; Hypertrophy - pathology ; Hypertrophy - therapy ; Kidney Failure, Chronic - metabolism ; Kidney Failure, Chronic - pathology ; Kidney Failure, Chronic - therapy ; Kidney Glomerulus - cytology ; Kidney Glomerulus - metabolism ; Kidney Glomerulus - pathology ; Ligation ; Mice ; Mice, Mutant Strains ; mouse model ; myofibroblasts ; nephrotic syndrome ; Sclerosis ; Ureter ; ureter ligation</subject><ispartof>Biochemical and biophysical research communications, 2001-06, Vol.284 (3), p.707-713</ispartof><rights>2001 Academic Press</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63</citedby><cites>FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11396960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mizuno-Horikawa, Yoko</creatorcontrib><creatorcontrib>Mizuno, Shinya</creatorcontrib><creatorcontrib>Tamura, Shinichi</creatorcontrib><creatorcontrib>Kurosawa, Tsutomu</creatorcontrib><title>Advanced Glomerulosclerosis Is Reversible in Nephrotic Mice</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Advanced glomerulosclerosis, a common hallmark of chronic renal diseases (CRD) is believed to be irreversible, and it is thought that glomerular hyperfiltration and hypertrophy may participate in its pathogenesis. We demonstrate here that glomerulosclerosis is “reversible” in an animal model. We used nephrotic ICGN (nep/nep) mice which showed a rapid progression of glomerulosclerosis, accompanied by histological findings for glomerular hyperfiltration. It is known that ureter ligation reduces glomerular filtration in ligated kidneys. When ureter ligation was applied to our model, glomerulosclerosis (characterized by myofibroblast hyperplasia and over-accumulated matrix protein) weakened in conjunction with suppressed glomerular hypertrophy. During this process, glomerular myofibroblasts showed apoptotic cell death after unilateral ureter ligation (UUO) treatment. Our results suggest that inhibition of glomerular filtration in sclerotic tufts may cause glomerular remodeling through the modulation of molecular and cellular sclerogenesis.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Fibroblasts</subject><subject>Fibronectins - metabolism</subject><subject>glomerular hypertrophy</subject><subject>glomerular remodeling</subject><subject>glomerulosclerosis</subject><subject>Glomerulosclerosis, Focal Segmental - metabolism</subject><subject>Glomerulosclerosis, Focal Segmental - pathology</subject><subject>Glomerulosclerosis, Focal Segmental - therapy</subject><subject>Hypertrophy - pathology</subject><subject>Hypertrophy - therapy</subject><subject>Kidney Failure, Chronic - metabolism</subject><subject>Kidney Failure, Chronic - pathology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kidney Glomerulus - cytology</subject><subject>Kidney Glomerulus - metabolism</subject><subject>Kidney Glomerulus - pathology</subject><subject>Ligation</subject><subject>Mice</subject><subject>Mice, Mutant Strains</subject><subject>mouse model</subject><subject>myofibroblasts</subject><subject>nephrotic syndrome</subject><subject>Sclerosis</subject><subject>Ureter</subject><subject>ureter ligation</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kMFLwzAUh4Mobk6vHqUnb61JmqYrnoboHEwFUfAWkpdXjLTrTNqB_70pG3jy9HjwvR_v9xFyyWjGKJU3xnjIOKUsExXNj8iU0YqmnFFxTKY0Eimv2MeEnIXwFSkmZHVKJozllawknZLbhd3pDaBNlk3Xoh-aLkCDvgsuJKuQvOIOfXCmwcRtkmfcfvqud5A8OcBzclLrJuDFYc7I-8P9291jun5Zru4W6xRyQfvUGCihAMxNidIaXYjSaDnnaIFqAYYVtualKKSIFWwta5kXkjNe13lhqrjNyPU-d-u77wFDr1oXAJtGb7AbgipjZSnLMoLZHoT4f_BYq613rfY_ilE16lKjLjXqUqOueHB1SB5Mi_YPP_iJwHwPYOy3c-hVAIejL-cRemU791_2L2QXeVQ</recordid><startdate>20010615</startdate><enddate>20010615</enddate><creator>Mizuno-Horikawa, Yoko</creator><creator>Mizuno, Shinya</creator><creator>Tamura, Shinichi</creator><creator>Kurosawa, Tsutomu</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010615</creationdate><title>Advanced Glomerulosclerosis Is Reversible in Nephrotic Mice</title><author>Mizuno-Horikawa, Yoko ; Mizuno, Shinya ; Tamura, Shinichi ; Kurosawa, Tsutomu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Fibroblasts</topic><topic>Fibronectins - metabolism</topic><topic>glomerular hypertrophy</topic><topic>glomerular remodeling</topic><topic>glomerulosclerosis</topic><topic>Glomerulosclerosis, Focal Segmental - metabolism</topic><topic>Glomerulosclerosis, Focal Segmental - pathology</topic><topic>Glomerulosclerosis, Focal Segmental - therapy</topic><topic>Hypertrophy - pathology</topic><topic>Hypertrophy - therapy</topic><topic>Kidney Failure, Chronic - metabolism</topic><topic>Kidney Failure, Chronic - pathology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kidney Glomerulus - cytology</topic><topic>Kidney Glomerulus - metabolism</topic><topic>Kidney Glomerulus - pathology</topic><topic>Ligation</topic><topic>Mice</topic><topic>Mice, Mutant Strains</topic><topic>mouse model</topic><topic>myofibroblasts</topic><topic>nephrotic syndrome</topic><topic>Sclerosis</topic><topic>Ureter</topic><topic>ureter ligation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mizuno-Horikawa, Yoko</creatorcontrib><creatorcontrib>Mizuno, Shinya</creatorcontrib><creatorcontrib>Tamura, Shinichi</creatorcontrib><creatorcontrib>Kurosawa, Tsutomu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mizuno-Horikawa, Yoko</au><au>Mizuno, Shinya</au><au>Tamura, Shinichi</au><au>Kurosawa, Tsutomu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advanced Glomerulosclerosis Is Reversible in Nephrotic Mice</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2001-06-15</date><risdate>2001</risdate><volume>284</volume><issue>3</issue><spage>707</spage><epage>713</epage><pages>707-713</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>Advanced glomerulosclerosis, a common hallmark of chronic renal diseases (CRD) is believed to be irreversible, and it is thought that glomerular hyperfiltration and hypertrophy may participate in its pathogenesis. We demonstrate here that glomerulosclerosis is “reversible” in an animal model. We used nephrotic ICGN (nep/nep) mice which showed a rapid progression of glomerulosclerosis, accompanied by histological findings for glomerular hyperfiltration. It is known that ureter ligation reduces glomerular filtration in ligated kidneys. When ureter ligation was applied to our model, glomerulosclerosis (characterized by myofibroblast hyperplasia and over-accumulated matrix protein) weakened in conjunction with suppressed glomerular hypertrophy. During this process, glomerular myofibroblasts showed apoptotic cell death after unilateral ureter ligation (UUO) treatment. Our results suggest that inhibition of glomerular filtration in sclerotic tufts may cause glomerular remodeling through the modulation of molecular and cellular sclerogenesis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>11396960</pmid><doi>10.1006/bbrc.2001.4903</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2001-06, Vol.284 (3), p.707-713 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_proquest_miscellaneous_70906677 |
source | ScienceDirect Journals |
subjects | Animals Apoptosis Fibroblasts Fibronectins - metabolism glomerular hypertrophy glomerular remodeling glomerulosclerosis Glomerulosclerosis, Focal Segmental - metabolism Glomerulosclerosis, Focal Segmental - pathology Glomerulosclerosis, Focal Segmental - therapy Hypertrophy - pathology Hypertrophy - therapy Kidney Failure, Chronic - metabolism Kidney Failure, Chronic - pathology Kidney Failure, Chronic - therapy Kidney Glomerulus - cytology Kidney Glomerulus - metabolism Kidney Glomerulus - pathology Ligation Mice Mice, Mutant Strains mouse model myofibroblasts nephrotic syndrome Sclerosis Ureter ureter ligation |
title | Advanced Glomerulosclerosis Is Reversible in Nephrotic Mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A51%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advanced%20Glomerulosclerosis%20Is%20Reversible%20in%20Nephrotic%20Mice&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Mizuno-Horikawa,%20Yoko&rft.date=2001-06-15&rft.volume=284&rft.issue=3&rft.spage=707&rft.epage=713&rft.pages=707-713&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1006/bbrc.2001.4903&rft_dat=%3Cproquest_cross%3E70906677%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c340t-bbc7c5ce3b7e6dba547ba682edc0a4cb15df274564490df6f6356212ff35b9f63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70906677&rft_id=info:pmid/11396960&rfr_iscdi=true |